Bacterial Pneumonia - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bacterial Pneumonia - Pipeline Review, H2 2016" report to their offering.

Bacterial pneumonia is an infection in one or both lungs. The bacteria cause the lung's air sacs (alveoli) to become inflamed and engorged with pus, fluid, and cellular debris. This often impairs the body's ability to exchange oxygen and carbon dioxide. Predisposing factors are age, long-term users of immunosuppressant drugs, chronic obstructive pulmonary disease (COPD) patients who use inhaled corticosteroids for lengthy periods and smokers. Symptoms include cough with yellow, green, or blood-tinged mucus, headache, muscle pain, breathlessness or rapid breathing, lethargy and confusion.

This report provides comprehensive information on the therapeutic development for Bacterial Pneumonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bacterial Pneumonia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Abera Bioscience AB
  • Actelion Ltd
  • Affinivax Inc
  • Allergan Plc
  • Aridis Pharmaceuticals LLC
  • Arsanis Inc
  • AstraZeneca Plc
  • Beijing Minhai Biotechnology Co Ltd
  • Biken Inc
  • ContraFect Corp
  • Crestone Inc
  • Daiichi Sankyo Company Ltd
  • Dong-A Socio Holdings Co Ltd
  • Double Bond Pharmaceutical International AB
  • Emergent BioSolutions Inc
  • FluGen Inc
  • GlaxoSmithKline Plc
  • ImmunoBiology Ltd
  • Indian Immunologicals Ltd
  • Integrated BioTherapeutics Inc
  • (20+ Others)

Key Topics Covered:

  1. Introduction
  2. Bacterial Pneumonia Overview
  3. Therapeutics Development
  4. Pipeline Products for Bacterial Pneumonia - Overview
  5. Pipeline Products for Bacterial Pneumonia - Comparative Analysis
  6. Bacterial Pneumonia - Therapeutics under Development by Companies
  7. Bacterial Pneumonia - Therapeutics under Investigation by Universities/Institutes
  8. Bacterial Pneumonia - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bacterial Pneumonia - Products under Development by Companies
  13. Bacterial Pneumonia - Products under Investigation by Universities/Institutes
  14. Bacterial Pneumonia - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/zkgjxw/bacterial

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs, Infectious Diseases Drugs